Nuformix plc (LON:NFX)
0.0900
+0.0090 (11.11%)
Feb 21, 2025, 5:07 PM BST
Nuformix Statistics
Total Valuation
Nuformix has a market cap or net worth of GBP 1.28 million. The enterprise value is 1.26 million.
Market Cap | 1.28M |
Enterprise Value | 1.26M |
Important Dates
The next estimated earnings date is Wednesday, March 19, 2025.
Earnings Date | Mar 19, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Nuformix has 1.42 billion shares outstanding. The number of shares has increased by 11.10% in one year.
Current Share Class | n/a |
Shares Outstanding | 1.42B |
Shares Change (YoY) | +11.10% |
Shares Change (QoQ) | +7.92% |
Owned by Insiders (%) | 6.59% |
Owned by Institutions (%) | 21.85% |
Float | 1.32B |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 1.03 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.35 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.23
Current Ratio | 0.23 |
Quick Ratio | 0.14 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -148.31% and return on invested capital (ROIC) is -12.89%.
Return on Equity (ROE) | -148.31% |
Return on Assets (ROA) | -11.75% |
Return on Invested Capital (ROIC) | -12.89% |
Return on Capital Employed (ROCE) | -70.76% |
Revenue Per Employee | n/a |
Profits Per Employee | -1.21M |
Employee Count | 3 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.42% in the last 52 weeks. The beta is 1.14, so Nuformix's price volatility has been higher than the market average.
Beta (5Y) | 1.14 |
52-Week Price Change | -68.42% |
50-Day Moving Average | 0.07 |
200-Day Moving Average | 0.11 |
Relative Strength Index (RSI) | 56.57 |
Average Volume (20 Days) | 126,796,063 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -506,353 |
Pretax Income | -3.65M |
Net Income | -3.64M |
EBITDA | -477,187 |
EBIT | -506,353 |
Earnings Per Share (EPS) | -0.00 |
Balance Sheet
Cash & Cash Equivalents | 20,210 |
Total Debt | n/a |
Net Cash | 20,210 |
Net Cash Per Share | 0.00 |
Equity (Book Value) | 715,571 |
Book Value Per Share | 0.00 |
Working Capital | -195,840 |
Cash Flow
Operating Cash Flow | -331,883 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Nuformix does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -11.10% |
Shareholder Yield | -11.10% |
Earnings Yield | -285.08% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |